Citation: A. Riva, Commento alla carta geomorfologica 1:30.000 dell'apparato morenico dell'Adda di Lecco di Sergio Venzo, Bollettino della Societa Geologica Italiana Italian Journal of Geosciences, 66, 1947, pp. 22-24
Citation: A. Riva, Notizie sul "glaciale" della Brianza, Bollettino della Societa Geologica Italiana Italian Journal of Geosciences, 60(01), 1941, pp. 50-64
Citation: M. Sella et al., Sintesi geopetrolifera della Fossa Bradanica (avanfossa della catena Appenninica meridionale), Memorie della Societa Geologica Italiana , 41, 1988, pp. 87-107
Citation: F. Mostardini et al., Appennino meridionale: caratteristiche geochimiche e mineralogiche delle "Argille Varicolori" incontrate da alcuni sondaggi, Memorie della Societa Geologica Italiana , 41, 1988, pp. 265-284
Authors:
RIBATTI D
BERTOSSI M
NICO B
VACCA A
RIA R
RIVA A
RONCALI L
PRESTA M
Citation: D. Ribatti et al., ROLE OF BASIC FIBROBLAST GROWTH-FACTOR IN THE FORMATION OF THE CAPILLARY PLEXUS IN THE CHICK-EMBRYO CHORIOALLANTOIC MEMBRANE - AN IN-SITU HYBRIDIZATION, IMMUNOHISTOCHEMICAL AND ULTRASTRUCTURAL-STUDY, Journal of submicroscopic cytology and pathology, 30(1), 1998, pp. 127-136
Citation: R. Bellazzi et A. Riva, LEARNING BAYESIAN NETWORKS PROBABILITIES FROM LONGITUDINAL DATA, IEEE transactions on systems, man and cybernetics. Part A. Systems and humans, 28(5), 1998, pp. 629-636
Authors:
DEVALERIOLA D
AWADA A
VANVRECKEM A
HABBOUBI N
RIVA A
PICCART M
Citation: D. Devaleriola et al., INFLUENCE OF AMIFOSTINE (A) ON THE TOXICITY AND PHARMACOKINETICS (PK)OF DOCETAXEL (D) IN BREAST-CANCER PATIENTS - AN EORTC-IDBBC STUDY, European journal of cancer, 34, 1998, pp. 76-76
Authors:
DILEO A
CROWN J
NOGARET LM
DUFFY K
BARTHOLOMEUS S
DOLCI S
ROWAN S
OHIGGINS N
RIVA A
PICCART MJ
Citation: A. Dileo et al., DOXORUBICIN (A) FOLLOWED BY DOCETAXEL (T) VERSUS DOXORUBICIN PLUS DOCETAXEL (AT) IN THE ADJUVANT TREATMENT OF BREAST-CANCER (BC), European journal of cancer, 34, 1998, pp. 166-166
Authors:
NABHOLTZ JM
MACKEY JR
SMYLIE M
PATERSON A
NOEL D
ALTWELGERI T
JANOWSKAWIECZOREK A
DELOME F
RIVA A
Citation: Jm. Nabholtz et al., FINAL RESULTS OF A PHASE-II STUDY OF TAXOTERE (DOCETAXEL, D), DOXORUBICIN (DX) AND CYCLOPHOSPHAMIDE (CTX) (TAC) IN THE TREATMENT OF METASTATIC BREAST-CANCER (MBC), European journal of cancer, 34, 1998, pp. 173-173
Authors:
DILEO A
CROWN J
NOGARET JM
DUFFY K
BARTHOLOMEUS S
ROWAN S
DOLCI S
OHIGGINS N
RIVA A
PICCART MJ
Citation: A. Dileo et al., FEASIBILITY OF DOCETAXEL (D)-CONTAINING REGIMENS IN THE ADJUVANT TREATMENT (AT) OF BREAST-CANCER (BC), European journal of cancer, 34, 1998, pp. 85-85
Citation: A. Riva et al., A DEVELOPMENT ENVIRONMENT FOR KNOWLEDGE-BASED MEDICAL APPLICATIONS ONTHE WORLD-WIDE-WEB, Artificial intelligence in medicine, 14(3), 1998, pp. 279-293
Citation: A. Riva, PROCEEDINGS OF THE 2ND SYMPOSIUM ON SALIVARY-GLANDS DEDICATED TO STEENSEN,NIELS (STENONE,NICCOLO), CAGLIARI, MAY 23-25, 1997 - INTRODUCTION, European journal of morphology, 36, 1998, pp. 1-1
Citation: A. Riva et Ft. Riva, HISTORICAL NOTE - GIANNUZZI,GIUSEPPE,ORONZO AND THE DISCOVERY OF THE SEROUS DEMILUNES AND OF THE INTERCELLULAR CANALICULI, European journal of morphology, 36, 1998, pp. 15-18
Authors:
RIVA A
LOFFREDO F
SEGAWA A
CONGIU T
RIVA FT
Citation: A. Riva et al., HUMAN SALIVARY-GLAND PARENCHYMAL-CELLS SEEN BY SEM FROM THE CYTOPLASMIC SIDE USING A NEW OSMIUM MACERATION METHOD, European journal of morphology, 36, 1998, pp. 35-40
Authors:
SEGAWA A
RIVA A
LOFFREDO F
CONGIU T
YAMASHINA S
RIVA FT
Citation: A. Segawa et al., CYTOSKELETAL REGULATION OF HUMAN SALIVARY SECRETION STUDIED BY HIGH-RESOLUTION ELECTRON-MICROSCOPY AND CONFOCAL LASER MICROSCOPY, European journal of morphology, 36, 1998, pp. 41-45
Authors:
PAGANI O
SESSA C
VANDENBULCKE T
MARTINELLI G
ZAMPINO G
NOLE F
ZIMATORE M
LOCATELLI M
CRIVELLARI D
BUONADONNA A
THURLIMANN B
HESS D
BORNER M
BAUER J
RIGGI M
RIVA A
GOLDHIRSCH A
Citation: O. Pagani et al., DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (D) AS FIRST-LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC), Annals of oncology, 9, 1998, pp. 74-74
Authors:
DIERAS V
MISSET JL
BOURGEOIS H
BOZEC L
GRUIA G
CVITKOVIC E
AUSSEL P
RIVA A
AZLI N
POUILLART P
Citation: V. Dieras et al., DOCETAXEL (TAXOTERE(TM)) (T) AND DOXORUBICIN (A) AS 1ST LINE CT OF METASTATIC BREAST-CANCER (MBC) - HIGH-ACTIVITY AND LACK OF CARDIOTOXICITY AFTER 29-MONTH FOLLOW-UP, Annals of oncology, 9, 1998, pp. 79-79
Authors:
MISSET JL
NABHOLTZ JM
DIERAS V
NOEL D
PATERSON A
ALTWEIGERI T
BOZEC L
RIVA A
AZLI N
POUILLART P
Citation: Jl. Misset et al., LONG-TERM FOLLOW-UP IN UNTREATED METASTATIC BREAST-CANCER (MBC) PTS TREATED WITH DOCETAXEL (TAXOTERE(TM)) (T) IN COMBINATION WITH DOXORUBICIN (A) - RESULTS OF 2 STUDIES, Annals of oncology, 9, 1998, pp. 119-119
Authors:
SESSA C
CALDIERA S
DEJONG J
MONNERAT C
PERARD D
VERNILLET L
RIVA A
BESENVAL M
BAUER J
Citation: C. Sessa et al., PHASE-I STUDY OF RPR109881A, A NEW TAXOID ADMINISTERED AS A 3 HOUR INTRAVENOUS-INFUSION TO PATIENTS (PTS) WITH ADVANCED SOLID TUMORS, Annals of oncology, 9, 1998, pp. 603-603
Authors:
AWADA A
DEVALERIOLA D
GIL T
KERGER J
SELLESLAGS J
MARIEN K
VANVRECKEM A
BRASSINNE C
HENNEBERT P
DEWJI R
RIVA A
PICCART M
Citation: A. Awada et al., INFLUENCE OF THE CYTOPROTECTIVE AGENT AMIFOSTINE ON TOXICITY AND PHARMACOKINETICS (PK) OF DOCETAXEL (D) IN METASTATIC BREAST-CANCER (MBC) -A FEASIBILITY STUDY OF THE EORTC-INVESTIGATIONAL DRUG BRANCH FOR BREAST-CANCER (IDBBC), Annals of oncology, 9, 1998, pp. 208-208
Authors:
DISTEFANO M
FERLINI C
PIERELLI L
DEVINCENZO R
RIVA A
BOMBARDELLI E
OJIMA I
MANCUSO S
SCAMBIA G
Citation: M. Distefano et al., ANTITUMOR AND MYELOTOXIC ACTIVITY OF A NEW CLASS OF TAXANES (14-BETA-HYDROXY-10-DEACETYLBACCATIN-III DERIVATIVES), Annals of oncology, 9, 1998, pp. 348-348
Authors:
ROSSI C
MINCIONE T
NICOLETTI I
BOMBARDELLI E
RIVA A
DONATI MB
GIAVAZZI R
Citation: C. Rossi et al., ANTITUMOR-ACTIVITY OF IDN-5109, A NEW TAXANE, ON HUMAN OVARIAN-CARCINOMA XENOGRAFTS, Annals of oncology, 9, 1998, pp. 349-349
Authors:
CALDIERA S
BAUER J
DEJONG J
MONNERAT C
PERARD D
VERNILLET L
RIVA A
BESENVAL M
SESSA C
Citation: S. Caldiera et al., A CLINICAL AND PHARMACOKINETIC (PK) PHASE-I STUDY OF RPR109881A, A NEW TAXOID ADMINISTERED AS A 3 HOUR INTRAVENOUS-INFUSION TO PATIENTS (PTS) WITH ADVANCED SOLID TUMORS, Annals of oncology, 9, 1998, pp. 359-359